Minimally invasive mitral valve replacement is expected to be the next major trend in structural heart, following in the success of transcatheter aortic valve replacement.
Middle Peak Medical is a privately held medical device company focused on a novel approach to treating mitral valve disease. Their technology is designed to restore mitral valve disease by providing a new posterior surface onto which the anterior leaflet can properly seal. Symetis announced earlier in the month the acquisition of Middle Peak Medical.
What will Medtronic, Boston Scientific & Abbott Vascular/ St Jude Medical do?
I’d love to hear your thoughts in the comment feed below!
Akbar Ali, Projectus Consulting